Aquestive Therapeutics Inc — 四半期キャッシュフロー (NASDAQ:AQST) | MetaTrader

チャート全体を表示

Financials

概要明細書統計

総資産 101.42 M102.23 M93.7 M163.56 M160.43 M 負債合計 161.58 M163.16 M166.29 M167.67 M194.09 M 純資産合計 -60.16 M-60.93 M-72.59 M-4.11 M-33.66 M 負債および純資産合計 101.42 M102.23 M93.7 M163.56 M160.43 M 有利子負債合計 50.48 M50.36 M50.24 M50.11 M49.97 M 純負債 50.48 M-18.3 M-10.3 M-78.95 M49.97 M

ニュース

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

Aquestive Therapeutics: Post-CRL Risk, Timeline, And Valuation (NASDAQ:AQST)

Aquestive Therapeuticsの最高人事責任者Boyd氏が12万4000ドル相当の株式を売却

Aquestive Therapeutics chief people officer Boyd sells $124k in stock

Aquestive TherapeuticsのCEO Barberが75万3965ドル相当の株式を売却

Aquestive TherapeuticsのSVP Cioffiが10万5000ドル相当の株式を売却

Aquestive Therapeuticsの最高法務責任者Braenderが16万7000ドル相当の株式を売却

Aquestive Therapeutics CEO Barber sells $753,965 in stock

Aquestive Therapeutics SVP Cioffi sells $105k in shares

Aquestive therapeutics chief legal officer Braender sells $167k in stock

Aquestive Therapeutics: With Some Hiccups, Anaphylm Is Closer To FDA Approval

Aquestive、Leerinkカンファレンスでアナフィルムに戦略的注力